Login / Signup

Central diabetes insipidus in pediatric patients with Langerhans cell histiocytosis: Results from the JLSG-96/02 studies.

Kenichi SakamotoAkira MorimotoYoko ShiodaToshihiko ImamuraShinsaku Imashukunull null
Published in: Pediatric blood & cancer (2018)
In the JLSG-96/02 studies, CDI developed in 15.8% of the cohort in which half as pre- and the other half as post-CDI. Relapse, particularly at the CNS risk sites, was linked with the development of post-CDI.
Keyphrases
  • case control
  • type diabetes
  • cardiovascular disease
  • single cell
  • cell therapy
  • stem cells
  • young adults
  • bone marrow
  • adipose tissue
  • skeletal muscle
  • breast cancer risk